Skip to content

Frontlight ResearchEarly access

Institution

Centre for the AIDS Programme of Research in South Africa

Durban, South AfricaWebsite

Also known as: CAPRISA

2running trials
1closed trial
2,307publications (OpenAlex)

Running trials

Recruiting
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
NCT07645378· Fred Hutchinson Cancer Center· Source
Recruiting
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT07209761· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Completed
Improving HIV-1 Control in Africa With Long Acting Antiretrovirals
NCT05546242· Phase 3· MRC/UVRI and LSHTM Uganda Research Unit· Source

Registry name variants (3)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

CAPRISA
Durban
1 trial
- NCT05546242Improving HIV-1 Control in Africa With Long Acting Antiretrovirals
Centre for the AIDS Programme of Research in South Africa
Durban
1 trial
- NCT07645378Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
  Contact: Nivashnee Naicker, MBChB, MAS, MPH
Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Durban, KwaZulu-Natal 4013
1 trial
- NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Conditions

Diseases this institution publishes on or runs trials for.

HIV107 works · 2 trials

Institution data: ROR 04qkg4668 (CC0-1.0)Updated 14 Nov 2026

Report an error

Centre for the AIDS Programme of Research in South Africa: trials and research groups – Frontlight Research